Twist Bioscience Corporation
TWST
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital dā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$127.22
Price+0.29%
$0.37
1Y
Price
Market Cap
$7.922b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-23.6%
EBITDA Margin-29.6%
Net Profit Margin-7.2%
Free Cash Flow Margin-23.6%
EBITDA Margin-29.6%
Net Profit Margin-7.2%
Free Cash Flow MarginRevenue
$431.798m
+14.7%
1y CAGR+20.9%
3y CAGR+20.8%
5y CAGREarnings
-$136.717m
-76.0%
1y CAGR-5.1%
3y CAGR-2.3%
5y CAGREPS
-$2.22
-70.8%
1y CAGR-2.3%
3y CAGR+1.0%
5y CAGRBook Value
$445.739m
$672.437m
Assets$226.698m
Liabilities$93.590m
DebtDebt to Assets
13.9%
-0.9x
Debt to EBITDAFree Cash Flow
-$93.123m
-23.1%
1y CAGR+9.0%
3y CAGR+12.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company